SKK
BMY icon

Shepherd Kaplan Krochuk’s Bristol-Myers Squibb BMY Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-9,000
Closed -$578K – 141
2019
Q4 		$578K Buy
+9,000
New +$515K 0.44% 76

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Shepherd Kaplan Krochuk's BMY Position: Q1 2020 in Review

Shepherd Kaplan Krochuk sold out of Bristol-Myers Squibb (BMY) in Q1 2020, closing a stake of 9,000 shares — an estimated $578K sold.

Shepherd Kaplan Krochuk first reported a position in BMY in Q4 2019 and held it in 1 quarter. The position peaked at $578K in Q4 2019. 2,149 funds tracked by Wall St. Rank hold BMY as of Q1 2020.

  • Shepherd Kaplan Krochuk reported no remaining Bristol-Myers Squibb position as of Q1 2020 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 9,000 Bristol-Myers Squibb shares in Q1 2020, an estimated $578K.
  • Shepherd Kaplan Krochuk first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 1 quarter.
  • Shepherd Kaplan Krochuk's Bristol-Myers Squibb position peaked at $578K in Q4 2019.
  • 2,149 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2020.

Based on Shepherd Kaplan Krochuk's 13F filing for Q1 2020, filed 12 May 2020.